CBUS on Nasdaq
Cibus, Inc.
Cibus’ business operates within the global seed market, where management estimates that aggregate trait value across both genetically modified organism (GMO) and non-GMO seeds globally represents.4 From its latest annual report
Price unavailable
Last updated Oct 19, 2026.
Overview
Compare with Evogene Ltd, SenesTech, Inc. or Bioceres Crop Solutions Corp., or pick any stock.
- TickerCBUS on Nasdaq1
- IndustryAgricultural Chemicals1
- HeadquartersSan Diego, California1
- Incorporated inDE3
- Business address6455 Nancy Ridge Drive, San Diego, Ca 921213
- Filer categoryNon-accelerated filer, Smaller reporting company3
See how the biggest companies compare on our leaderboards
Cibus’ business operates within the global seed market, where management estimates that aggregate trait value across both genetically modified organism (GMO) and non-GMO seeds globally represents approximately $12.0 billion.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2025
Where the money goes
Where each dollar of revenue went, fiscal 2025
- Research and development62¢$44.2M
- Selling, general and admin38¢$26.9M
- Income tax0¢$29.0K
Out of $3.6M in revenue.2 The company lost money this year.
Financial statements
Every line of the income statement as filed: the last 2 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Total revenue | $3.6M | $4.3M |
| Research and development | $44.2M | $50.4M |
| Selling, general, and administrative | $26.9M | $30.8M |
| Goodwill impairment | $20.9M | $181.4M |
| Long-lived assets impairment | $9.1M | $0 |
| Total operating expenses | $101.2M | $262.7M |
| Loss from operations | -$97.5M | -$258.4M |
| Royalty liability interest expense - related parties | -$35.5M | -$34.2M |
| Other interest income, net | $438.0K | $631.0K |
| Non-operating income, net | $400.0K | $9.3M |
| Loss before income taxes | -$132.2M | -$282.7M |
| Income tax expense | -$29.0K | -$29.0K |
| Net loss | -$132.2M | -$282.7M |
| Net loss attributable to noncontrolling interest and redeemable noncontrolling interest | -$5.1M | -$31.3M |
| Net loss attributable to Cibus, Inc. stockholders | -$127.1M | -$251.4M |
| Basic net loss per share of Class A common stock (in dollars per share) | -$2.78 | -$10.83 |
| Diluted net loss per share of Class A common stock (in dollars per share) | -$2.78 | -$10.83 |
| Weighted average shares of Class A common stock outstanding - basic (in shares) | 45.8M shares | 23.2M shares |
| Weighted average shares of Class A common stock outstanding - diluted (in shares) | 45.8M shares | 23.2M shares |
No quarter-by-quarter statement was filed.
Every line of the balance sheet as filed: the last 4 fiscal years (annual) or 4 quarters (quarterly), latest first.2
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-05-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $9.9M | $14.4M | ||
| Accounts receivable | $503.0K | $1.0M | $500.0K | |
| Prepaid expenses and other current assets | $1.6M | $1.5M | ||
| Total current assets | $12.1M | $16.9M | ||
| Property, plant, and equipment, net | $6.3M | $11.4M | ||
| Operating lease right-of-use assets | $21.6M | $33.3M | ||
| Intangible assets, net | $31.7M | $33.6M | ||
| Goodwill | $232.5M | $253.5M | $434.9M | |
| Other non-current assets | $926.0K | $1.4M | ||
| Total assets | $305.0M | $350.1M | ||
| Accounts payable | $8.1M | $6.0M | ||
| Accrued expenses | $1.9M | $2.3M | ||
| Accrued compensation | $3.1M | $3.3M | ||
| Deferred revenue | $536.0K | $932.0K | $1.2M | |
| Current portion of notes payable | $435.0K | $436.0K | ||
| Current portion of financing lease obligations | $0 | $113.0K | ||
| Current portion of operating lease obligations | $2.7M | $4.3M | ||
| Class A common stock warrants | $79.0K | $2.3M | ||
| Other current liabilities | $0 | $288.0K | ||
| Total current liabilities | $16.9M | $19.9M | ||
| Notes payable, net of current portion | $93.0K | $226.0K | ||
| Operating lease obligations, net of current portion | $29.8M | $31.2M | ||
| Royalty liability - related parties | $234.9M | $199.4M | ||
| Other non-current liabilities | $1.6M | $1.5M | ||
| Total liabilities | $283.2M | $252.2M | ||
| Redeemable noncontrolling interest | $0 | $5.7M | $44.8M | |
| Additional paid-in capital | $882.2M | $825.3M | ||
| Class A common stock in treasury, at cost; 193,195 shares as of December 31, 2025, and 45,177 shares as of December 31, 2024 | -$2.1M | -$2.0M | ||
| Accumulated deficit | -$858.3M | -$731.2M | ||
| Accumulated other comprehensive income | $39.0K | $15.0K | ||
| Total stockholders equity | $21.8M | $92.2M | ||
| Total liabilities, redeemable noncontrolling interest, and stockholders equity | $305.0M | $350.1M | ||
| Common stock, par value (in dollars per share) | $0.00 | |||
| Common stock, shares authorized (in shares) | 300.0M shares | |||
| Treasury stock, shares (in shares) | 193.2K shares | 45.2K shares |
| Period ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2023-05-31 |
|---|---|---|---|---|
| Cash and cash equivalents | $9.9M | $14.4M | ||
| Accounts receivable | $503.0K | $1.0M | $500.0K | |
| Prepaid expenses and other current assets | $1.6M | $1.5M | ||
| Total current assets | $12.1M | $16.9M | ||
| Property, plant, and equipment, net | $6.3M | $11.4M | ||
| Operating lease right-of-use assets | $21.6M | $33.3M | ||
| Intangible assets, net | $31.7M | $33.6M | ||
| Goodwill | $232.5M | $253.5M | $434.9M | |
| Other non-current assets | $926.0K | $1.4M | ||
| Total assets | $305.0M | $350.1M | ||
| Accounts payable | $8.1M | $6.0M | ||
| Accrued expenses | $1.9M | $2.3M | ||
| Accrued compensation | $3.1M | $3.3M | ||
| Deferred revenue | $536.0K | $932.0K | $1.2M | |
| Current portion of notes payable | $435.0K | $436.0K | ||
| Current portion of financing lease obligations | $0 | $113.0K | ||
| Current portion of operating lease obligations | $2.7M | $4.3M | ||
| Class A common stock warrants | $79.0K | $2.3M | ||
| Other current liabilities | $0 | $288.0K | ||
| Total current liabilities | $16.9M | $19.9M | ||
| Notes payable, net of current portion | $93.0K | $226.0K | ||
| Operating lease obligations, net of current portion | $29.8M | $31.2M | ||
| Royalty liability - related parties | $234.9M | $199.4M | ||
| Other non-current liabilities | $1.6M | $1.5M | ||
| Total liabilities | $283.2M | $252.2M | ||
| Redeemable noncontrolling interest | $0 | $5.7M | $44.8M | |
| Additional paid-in capital | $882.2M | $825.3M | ||
| Class A common stock in treasury, at cost; 193,195 shares as of December 31, 2025, and 45,177 shares as of December 31, 2024 | -$2.1M | -$2.0M | ||
| Accumulated deficit | -$858.3M | -$731.2M | ||
| Accumulated other comprehensive income | $39.0K | $15.0K | ||
| Total stockholders equity | $21.8M | $92.2M | ||
| Total liabilities, redeemable noncontrolling interest, and stockholders equity | $305.0M | $350.1M | ||
| Common stock, par value (in dollars per share) | $0.00 | |||
| Common stock, shares authorized (in shares) | 300.0M shares | |||
| Treasury stock, shares (in shares) | 193.2K shares | 45.2K shares |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
Every line of the cash flow as filed: the last 2 fiscal years, latest first.2
| Period ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Net loss | -$132.2M | -$282.7M |
| Royalty liability interest expense - related parties | $35.5M | $34.2M |
| Goodwill impairment | $20.9M | $181.4M |
| Long-lived assets impairment | $9.1M | $0 |
| Depreciation and amortization | $5.9M | $6.9M |
| Stock-based compensation | $8.2M | $10.8M |
| Loss on disposal of assets, net | $41.0K | $335.0K |
| Change in fair value of liability classified Class A common stock warrants | -$447.0K | -$9.3M |
| Other | $38.0K | $22.0K |
| Accounts receivable | $538.0K | -$512.0K |
| Prepaid expenses and other current assets | $983.0K | $518.0K |
| Accounts payable | $720.0K | -$188.0K |
| Accrued expenses | -$367.0K | $608.0K |
| Accrued compensation | -$268.0K | -$535.0K |
| Deferred revenue | -$403.0K | -$285.0K |
| Right-of-use assets and lease obligations, net | $1.1M | $990.0K |
| Other assets and liabilities, net | -$28.0K | -$213.0K |
| Net cash used in operating activities | -$50.6M | -$58.0M |
| Purchases of property, plant, and equipment | -$578.0K | -$808.0K |
| Net cash used in investing activities | -$578.0K | -$808.0K |
| Proceeds from issuances of securities | $50.1M | $43.9M |
| Costs incurred related to issuances of securities | -$2.2M | -$2.2M |
| Payment of taxes related to restricted stock units withheld from employees | -$142.0K | -$214.0K |
| Proceeds from issuance of notes payable | $0 | $204.0K |
| Repayments of financing lease obligations | -$113.0K | -$171.0K |
| Repayments of notes payable | -$995.0K | -$912.0K |
| Net cash provided by financing activities | $46.6M | $40.6M |
| Effect of exchange rate changes on cash and cash equivalents | $11.0K | -$13.0K |
| Net decrease in cash and cash equivalents | -$4.5M | -$18.3M |
No quarter-by-quarter statement was filed.
Leadership
Who has led Cibus, Inc., and when. Pick a name to see everywhere that person has worked.
Chief executive
Chair
Chief financial officer
Chief operating officer
- Chief executive officerCraig Wichner Jun 10, 2026 to now15
- Chief executive officerPeter Beetham Jan 10, 2025 to Jun 10, 202616
- Chief executive officerMichael A. Carr Jul 28, 2021 to Jun 2, 202317
- Chief executive officerJames Blome Oct 10, 2018 to Jan 4, 202118
- Chief executive officerFederico A. Tripodi Jul 20, 2017 to Jun 15, 201819
- ChairYves J. Ribeill May 5, 2021 to Jul 28, 202120
- PresidentPeter Beetham Jan 10, 2025 to now16
- PresidentMichael A. Carr Jul 28, 2021 to Jun 2, 202317
- Chief financial officerCarlo Broos Oct 11, 2024 to now21
- Chief financial officerWade Hampton King Jun 2, 2023 to Jun 2, 202322
- Chief financial officerWilliam Koschak Jan 14, 2019 to Jun 2, 202323
- Chief financial officerEric Dutang Jul 2, 2018 to Jul 2, 201824
- Chief financial officerBryan W.j. Corkal Jul 20, 2017 to Jun 18, 201825
- Chief operating officerPeter Beetham Mar 27, 2025 to now26
Board members and other officers (32)
- CAO, Gen Csl & Corp SecyJason Stokes Apr 28, 2026 to now27
- SVP, ResearchNoel Sauer Mar 28, 2025 to now28
- OfficerGregory Francis William Gocal Jun 2, 2023 to now29
- OfficerPeter Beetham Jun 2, 2023 to Jun 2, 202330
- Chief Business OfficerSarah Reiter May 10, 2021 to Jun 10, 202131
- Chief Technology OfficerTravis Frey May 21, 2019 to Jun 2, 202332
- Chief Science OfficerDaniel F. Voytas Jul 20, 2017 to Jan 5, 202133
- Chief Operations OfficerFeng Zhang Jul 20, 2017 to Jul 20, 201734
- Vice President of BreedingGlenn R. Bowers Jul 20, 2017 to Jun 15, 201835
- Chief Commercial OfficerManoj Sahoo Jul 20, 2017 to Jul 2, 201936
- Director of Bus. DevelopmentMichel Arbadji Jul 20, 2017 to Jun 22, 201837
- Board memberKimberly Ann Box Sep 26, 2025 to now38
- Board memberCraig Wichner Nov 25, 2025 to now39
- Board memberAugust J. Moretti Nov 25, 2024 to now40
- Board memberGerhard Prante Jun 2, 2023 to now41
- Board memberJean-Pierre Jules Lehmann Jun 2, 2023 to now42
- Board memberKeith Allen Walker Jun 2, 2023 to now43
- Board memberMark Terrence Finn Jun 2, 2023 to now44
- Board memberPeter Beetham Jun 2, 2023 to now30
- Board memberJim Collins Sep 25, 2023 to Sep 25, 202345
- Board memberMichael A. Carr Jul 28, 2021 to Mar 29, 202317
- Board memberKimberly K. Nelson Jan 28, 2019 to Jun 1, 202346
- Board memberYves J. Ribeill Jul 13, 2018 to Jun 1, 202347
- Board memberFassberg Jonathan Aug 27, 2018 to Jun 1, 202348
- Board memberChristopher J. Neugent Sep 17, 2018 to Jun 1, 202349
- Board memberAlain Godard Jul 20, 2017 to Jun 25, 201850
- Board memberAnna Ewa Kozicz-Stankiewicz Jul 20, 2017 to Jun 1, 202351
- Board memberLaurent Arthaud Jul 20, 2017 to Jul 16, 202052
- Board memberPhilippe Dumont Jul 20, 2017 to Jun 1, 202353
- General counselJason Stokes Mar 28, 2025 to now54
- General counselDebra H. Frimerman Mar 6, 2019 to Jun 2, 202355
- General counselJoseph Saluri Jul 20, 2017 to Jul 20, 201756
Former names
- Calyxt, Inc.May 15, 2017 to Jun 1, 20233
Timeline
- Jun 10, 2026New chief executive Craig Wichner becomes CEO15
- Jan 10, 2025New chief executive Peter Beetham becomes CEO16
- Jul 28, 2021New chief executive Michael A. Carr becomes CEO17
- Oct 10, 2018New chief executive James Blome becomes CEO18
- Jul 20, 2017New chief executive Federico A. Tripodi becomes CEO19
Filings
421 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 95 major events, 188 insider forms, 17 large holders, 100 other. The latest 20:
- Aug 13, 202610-Q EDGAR
- Aug 13, 20268-K EDGAR
- Jun 23, 2026S-8 EDGAR
- Jun 23, 2026S-8 EDGAR
- Jun 10, 20264 PRIMARY DOCUMENT EDGAR
- Jun 9, 20268-K EDGAR
- Jun 5, 20268-K EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- Jun 4, 20264 PRIMARY DOCUMENT EDGAR
- May 22, 2026EFFECT EDGAR
- May 22, 2026424B3 EDGAR
- May 22, 2026424B2 EDGAR
- May 20, 2026CORRESP EDGAR
- May 19, 2026UPLOAD EDGAR
The 421 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
67 open-market trades by officers, directors and large owners since October 2021: 2 buys and 65 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Jun 13, 2025 | Sauer NoelSr VP, Research | Sale | 4 | $1.49 | $6 | Form 4 |
| Feb 25, 2025 | Prante GerhardDirector | Sale | 1,150 | $1.92 | $2.2K | Form 4 |
| Feb 24, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.07 | $2.4K | Form 4 |
| Feb 21, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.20 | $2.5K | Form 4 |
| Feb 20, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.35 | $2.7K | Form 4 |
| Feb 19, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.58 | $3.0K | Form 4 |
| Feb 18, 2025 | Prante GerhardDirector | Sale | 2,300 | $2.52 | $5.8K | Form 4 |
| Feb 14, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.60 | $3.0K | Form 4 |
| Feb 13, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.53 | $2.9K | Form 4 |
| Feb 12, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.45 | $2.8K | Form 4 |
| Feb 11, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.48 | $2.9K | Form 4 |
| Feb 10, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.52 | $2.9K | Form 4 |
| Feb 7, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.50 | $2.9K | Form 4 |
| Feb 6, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.55 | $2.9K | Form 4 |
| Feb 5, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.52 | $2.9K | Form 4 |
| Feb 4, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.45 | $2.8K | Form 4 |
| Feb 3, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.41 | $2.8K | Form 4 |
| Jan 31, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.55 | $2.9K | Form 4 |
| Jan 30, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.46 | $2.8K | Form 4 |
| Jan 29, 2025 | Prante GerhardDirector | Sale | 1,150 | $2.42 | $2.8K | Form 4 |
All 67 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- FMR LLCSCHEDULE 13G/A, 6 filings Feb 9, 2022 to May 6, 202657
- ARMISTICE CAPITAL, LLCSCHEDULE 13G/A, 2 filings May 15, 2025 to Aug 14, 202558
- Rory B. RiggsSCHEDULE 13D/A, 2 filings Jun 12, 2023 to Jun 10, 202559
- JPL Investments SASC 13D, 1 filing Jun 12, 202360
- Mark Terrence FinnSC 13D, 1 filing Jun 12, 202361
- Amova Asset Management Americas, Inc.SC 13G/A, 1 filing Feb 14, 202262
- Sumitomo Mitsui Trust GroupSC 13G/A, 1 filing Feb 4, 202263
Held by these funds
The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026, the top 25 of 62. Change is in shares since the quarter before.
| Fund | Shares | Value | Share of the fund | Change |
|---|---|---|---|---|
| Fmr LLC | 11,449,660 | $15.7M | 0.0% | +23,731 |
| Vanguard Capital Management LLC | 2,299,966 | $3.2M | 0.0% | +181,470 |
| United Capital Financial Advisors, LLC | 576,043 | $789.2K | 0.0% | No change |
| Geode Capital Management, LLC | 528,233 | $723.9K | 0.0% | +45,324 |
| BlackRock, Inc. | 492,795 | $675.1K | 0.0% | +77,619 |
| Coppell Advisory Solutions LLC | 250 | $465.2K | 0.0% | New |
| Certior Financial Group, LLC | 337,710 | $462.7K | 0.3% | +19,507 |
| Prescott Group Capital Management, L.L.C. | 328,157 | $449.6K | 0.0% | No change |
| Squarepoint Ops LLC | 312,340 | $427.9K | 0.0% | +237 |
| Vanguard Fiduciary Trust Co | 310,136 | $424.9K | 0.0% | +51,988 |
| Corient Private Wealth LP | 164,974 | $226.0K | 0.0% | No change |
| State Street Corp | 157,189 | $215.3K | 0.0% | No change |
| LPL Financial LLC | 142,431 | $195.1K | 0.0% | +37,138 |
| Renaissance Technologies LLC | 132,500 | $181.5K | 0.0% | +33,600 |
| Northern Trust Corp | 130,935 | $179.4K | 0.0% | +26,224 |
| Capital Advisor Network LLC | 129,975 | $178.1K | 0.2% | +52,351 |
| Lynx Capital Group Ltd /adv | 74,000 | $101.4K | 0.0% | +20,000 |
| Summit Trail Advisors, LLC | 69,114 | $94.7K | 0.0% | No change |
| Citigroup Inc | 63,564 | $87.1K | 0.0% | +50,291 |
| Moneta Group Investment Advisors LLC | 59,474 | $81.5K | 0.0% | New |
| Millennium Management LLC | 59,004 | $80.8K | 0.0% | −366,038 |
| Raymond James Financial Inc | 51,107 | $70.0K | 0.0% | −2,693 |
| Bokf, Na | 50,000 | $68.5K | 0.0% | New |
| UBS Group AG | 49,301 | $67.5K | 0.0% | −6,920 |
| Two Sigma Investments, LP | 48,831 | $66.9K | 0.0% | −37,375 |
13F reports cover disclosed long positions in U.S. stocks only.
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1SEC EDGARCibus, Inc. filings on SEC EDGAR
- 2SEC EDGARCibus, Inc. 10-K for fiscal 2025
- 3SEC EDGARCibus, Inc. filings on SEC EDGAR
- 4
- 5SEC EDGARCibus, Inc. 10-K for fiscal 2018
- 6SEC EDGARCibus, Inc. 10-K for fiscal 2019
- 7SEC EDGARCibus, Inc. 10-K for fiscal 2020
- 8SEC EDGARCibus, Inc. 10-K for fiscal 2022
- 9SEC EDGARCibus, Inc. 10-K for fiscal 2023
- 10SEC EDGARCibus, Inc. 10-Q for fiscal 2025
- 11SEC EDGARCibus, Inc. 10-Q for fiscal 2025
- 12SEC EDGARCibus, Inc. 10-Q for fiscal 2026
- 13SEC EDGARCibus, Inc. 10-K for fiscal 2018
- 14SEC EDGARCibus, Inc. 10-Q for fiscal 2025
- 15
- 16
- 17
- 18SEC EDGARJames Blome, Chief executive officer
- 19
- 20SEC EDGARYves J. Ribeill, Chair
- 21SEC EDGARCarlo Broos, Chief financial officer
- 22
- 23
- 24SEC EDGAREric Dutang, Chief financial officer
- 25
- 26
- 27
- 28SEC EDGARNoel Sauer, SVP, Research
- 29
- 30SEC EDGARPeter Beetham, Officer
- 31SEC EDGARSarah Reiter, Chief Business Officer
- 32
- 33
- 34SEC EDGARFeng Zhang, Chief Operations Officer
- 35
- 36
- 37
- 38SEC EDGARKimberly Ann Box, Board member
- 39SEC EDGARCraig Wichner, Board member
- 40SEC EDGARAugust J. Moretti, Board member
- 41SEC EDGARGerhard Prante, Board member
- 42
- 43SEC EDGARKeith Allen Walker, Board member
- 44SEC EDGARMark Terrence Finn, Board member
- 45SEC EDGARJim Collins, Board member
- 46SEC EDGARKimberly K. Nelson, Board member
- 47SEC EDGARYves J. Ribeill, Board member
- 48SEC EDGARFassberg Jonathan, Board member
- 49SEC EDGARChristopher J. Neugent, Board member
- 50SEC EDGARAlain Godard, Board member
- 51
- 52SEC EDGARLaurent Arthaud, Board member
- 53SEC EDGARPhilippe Dumont, Board member
- 54SEC EDGARJason Stokes, General counsel
- 55SEC EDGARDebra H. Frimerman, General counsel
- 56SEC EDGARJoseph Saluri, General counsel
- 57
- 58
- 59
- 60
- 61
- 62
- 63